Emergent BioSolutions Acquires Adapt Pharma Operations

ADAPT Pharma, Inc. is solely focused on helping address the opioid overdose and addiction crisis. It distributes NARCAN® (naloxone HCl) Nasal Spray, the major FDA approved emergency treatment for opioid overdose, to health agencies, first responders and retail pharmacies. It also has a development pipeline of potential opioid overdose and addiction treatment options. Emergent is a leader in the development, supply and provision of medical countermeasures for accidental, intentional and naturally occurring public health threats as well as emerging infectious diseases.